Study title:
Bentzinger C*,Biziere K,Plovin P,Dulac O,Chiron C,Girod R,Hewson G,Metcalfe S,Siegel J L, Clinical Final Study Report: Open-label exploratory study of the effects of acute i.v. flumazenil on interictal epileptic activity in pediatric patients with treated or untreated Lennox-Gastaut syndrome
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUMAZENIL |
ATC code: V03AB25
|
Document link:
|
Document date:
|
Study number: B-0156226 |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
Y
|
Y
|
Y
|